The technical advances of sacral nerve stimulation testing phase, namely the use of a tined lead and two phase testing, have improved the results during the last decade. [4] However, the complex ...

Medtronic secured approval from the US Food and Drug Administration (FDA) for its closed-loop spinal cord stimulation (SCS) device, designed to adjust stimulation in real-time, for the treatment ...

Several studies have demonstrated excellent results for sacral nerve stimulation (SNS) in the treatment of incapacitating fecal incontinence. The devices used for SNS are expensive, however, ...

Contemporary techniques for sacral nerve stimulation (SNS) are considered to involve easy, straightforward procedures and minimal invasiveness. As a result, SNS is now routinely incorporated into ...

Medtronic); this was inserted into the third sacral nerve foramen and connected to a temporary external neurostimulator to test the efficacy of stimulation. The electrodes on the tip of the lead ...

Inceptiv is a small device, implanted in the lower torso with leads to the spinal cord, that provides responsive counter-stimulation to relieve chronic pain. The device was approved by the FDA in ...

the completion of Medtronic education courses and successful implantation of a minimum of 500 patients with the InterStim system, among others. InterStim therapy utilizes sacral nerve stimulation ...

Intraoperative NIM nerve monitoring systems enable surgeons to identify, confirm, and monitor motor nerve function to help reduce the risk of nerve damage during various procedures, including ENT ...

LivaNova today announced that its OSPREY trial of nerve stimulation for treating sleep apnea met its primary endpoints.

The NIM-Response® 3.0 and NIM-Neuro® 3.0 offer advanced nerve monitoring technology with an easy-to-use interface. NIM® systems monitor EMG activity from multiple mucles. If there is a change ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...